VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
AstraZeneca PLC vs PepsiCo, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
AstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisPepsiCo, Inc.
PEP · Nasdaq Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into PepsiCo, Inc.'s moat claims, evidence, and risks.
View PEP analysisComparison highlights
- Moat score gap: PepsiCo, Inc. leads (72 / 100 vs 71 / 100 for AstraZeneca PLC).
- Segment focus: AstraZeneca PLC has 6 segments (41% in Oncology); PepsiCo, Inc. has 7 segments (27% in Frito-Lay North America (FLNA)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: AstraZeneca PLC has 4 moat types across 3 domains; PepsiCo, Inc. has 4 across 2.
Primary market context
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
PepsiCo, Inc.
Frito-Lay North America (FLNA)
Branded convenient foods (salty snacks, dips and adjacent categories)
United States and Canada
Retailers, convenience stores, foodservice
Branded manufacturer + distributor (DSD/warehouse/distributor networks)
27%
Side-by-side metrics
Moat coverage
Shared moat types
AstraZeneca PLC strengths
PepsiCo, Inc. strengths
Segment mix
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
PepsiCo, Inc. segments
Full profile >Frito-Lay North America (FLNA)
Oligopoly
Quaker Foods North America (QFNA)
Competitive
PepsiCo Beverages North America (PBNA)
Oligopoly
Latin America (LatAm)
Oligopoly
Europe
Oligopoly
Africa, Middle East and South Asia (AMESA)
Competitive
Asia Pacific, Australia & New Zealand and China Region (APAC)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.